Melanotan II

FDA APPROVAL PENDING

Well Studied

Skin

Sexual

Skin

Melanotan II

Sexual

Amino acid sequence

7

Amino acids

1024.2da

Molecular weight

Peptide

Type

Melanotan II is a synthetic analog of alpha-melanocyte-stimulating hormone (α-MSH) that activates melanocortin receptors throughout the body. MC1R activation triggers melanin production for tanning, while MC4R affects sexual arousal and appetite control.

Top researched benefits

Overview of Melanotan II

Binds to melanocortin receptors (MC1R for tanning, MC4R for sexual function and appetite) to stimulate melanin production, enhance libido, and suppress appetite through hypothalamic pathways.

Skin Health

  • Stimulates natural melanin production for tanning without requiring UV exposure.
  • Increased melanin provides natural SPF protection against sun damage.
  • May help address certain pigmentation disorders.

Sexual Health

  • Improves sexual desire in both men and women through MC4R activation.
  • 80% response rate in psychogenic erectile dysfunction studies.
  • 73% of women reported arousal within 24 hours in clinical trials.

Metabolic

  • MC4R activation in hypothalamus reduces appetite (15% caloric intake reduction in studies).
  • Enhanced fat oxidation through metabolic pathway activation.

Storage

Refrigerate at 2-8°C wrapped in aluminum foil (light-sensitive); use reconstituted solution within 4 weeks

Frequency

Loading phase: Daily for first week, then tanning maintenance 2-3x weekly or as needed for sexual enhancement

Typical Dose

Loading: Start 0.25mg daily, increase to 0.5-1mg; Maintenance: 0.5-1mg 2-3x weekly

Cycle Duration

4-8 weeks loading phase for tanning, then ongoing maintenance as needed

Chemical Makeup

Key benefits

Rapid tanning without UV exposure

Enhanced sexual function and libido

Appetite suppression

Improved mood via melanocortin activation

Photoprotection through increased melanin

Community interest

This peptide is still gaining traction in the community.

Synthetic Melanocortin Peptide | Tanning & Sexual Function

This overview is informational and based on aggregated descriptions from studies and user reports.

Was it helpful?Yes

Melanotan II Molecular Information

View the scientifc details of Melanotan II.

7

Amino Acids

Melanotan II

?

?

Position 1

Asp

Asp

Position 2

His

His

Position 3

Phe

Phe

Position 4

Arg

Arg

Position 5

Trp

Trp

Position 6

Lys

Lys

Position 7

Amino acid sequence
?Position 1
Aspartic acidPosition 2
HistidinePosition 3
PhenylalaninePosition 4
ArgininePosition 5
TryptophanPosition 6
LysinePosition 7

Molecular Weight

1024.2Da

Chain Length

7Amino Acids

Type

Peptide

Melanotan II Protocols

Subcutaneous injection is the standard and most effective route. Start with low doses to assess tolerance due to nausea risk.

GoalDosageFrequencyRoute
Initial loading phase0.251 week rangeSubQ
Tanning maintenance0.52 week rangeSubQ
Sexual enhancement0.5SubQ
Minimal side effects0.1SubQ
Photoprotection0.52 week rangeSubQ

Reconstitution Instructions

Materials needed:

Melanotan II lyophilized powder (typically 10mg vial)Bacteriostatic water (2mL for 5mg/mL concentration)Insulin syringesAlcohol swabsAluminum foil (light protection)

Steps to reconstitute

  1. Clean vial tops with alcohol swab, let dry
  2. Draw 2mL bacteriostatic water for 10mg vial (creates 5mg/mL)
  3. Inject water slowly down vial side to avoid foaming
  4. Gently roll vial - do not shake vigorously
  5. Solution should be clear to slightly yellow
  6. Wrap vial in foil (MT-II is light sensitive)
  7. Store in refrigerator
  8. Draw dose with insulin syringe (typical: 0.05-0.2mL)

Melanotan II Cycle

The Melanotan II Cycle section explains how long a typical cycle lasts and what to expect during each phase. Over time, your body can become less responsive with continuous use.

Taking breaks between cycles may help maintain effectiveness and support better overall results.

Day 1-3
Possible nausea, flushing, fatigue
Day 3-7
Increased spontaneous erections (men), enhanced arousal
Week 1-2
Noticeable skin darkening, reduced appetite
Week 2-4
Significant tanning, stabilized sexual effects
Week 0-0
Maintained tan with less frequent dosing

Dosing tools

Melanotan II Peptide Dosage Calculator

Calculate peptide doses with our visual syringe guide.

0.3mL / 30 units

5 units

0.050 mL

1 mL

2 mL

3 mL

5 mL

Custom

Conversion: 1,000 mcg = 1 mg

Injection Results

Based on your vial and dilution inputs.

Safe concentration range

Melanotan II

SINGLE COMPOUND

Volume per injection

0.05

mL

Concentration

10.00

mg/mL

Doses per vial

20

doses

Total injections per vial

20 injections

How it works

Based on a 10 mg Melanotan II vial diluted with 1 mL of bacteriostatic water, each 500 mcg injection equals 0.05 mL.

Research Purposes Only

These calculators are provided for educational and research purposes only. Always verify calculations and consult with qualified professionals. The information provided is not medical advice. Peptides should only be used in accordance with applicable laws and regulations.

Reference Guide

Dosing Cycle

Peptide
Melanotan II
Dosing
Loading: Start 0.25mg daily, increase to 0.5-1mg; Maintenance: 0.5-1mg 2-3x weekly
Dosing Frequency
Loading phase: Daily for first week, then tanning maintenance 2-3x weekly or as needed for sexual enhancement
Cycle Duration
4-8 weeks loading phase for tanning, then ongoing maintenance as needed
Storage
Refrigerate at 2-8°C wrapped in aluminum foil (light-sensitive); use reconstituted solution within 4 weeks

Note: Triple agonist; microdose for fewer side effects

Reconstitution Tips

  • Use bacteriostatic water (BAC)contains 0.9% benzyl alcohol for preservation
  • Inject water slowlyaim down the vial wall, not directly onto powder
  • Never shakegently swirl or roll the vial until dissolved
  • Store properlyrefrigerate at 2-8°C after reconstitution
  • Use within 28 daysmost reconstituted peptides remain stable for about 4 weeks
  • Keep sterilealways clean vial tops with alcohol before drawing

Peptide Interactions

Research suggestions of Melanotan II interactions with other common peptides and substances.

Healing

bpc

Longevity

BPC-157

COMPATIBLE

No known interactions.

COMPATIBLE

Side effects

Contraindications

History of melanoma or dysplastic nevi

Pregnancy or breastfeeding

Cardiovascular conditions

Uncontrolled hypertension

Stop signs

Severe persistent nausea or vomiting

Chest pain or significant blood pressure elevation

Mole changes (size, shape, color) - monitor closely

Prolonged painful erections (priapism)

Severe headaches or vision changes

Allergic reactions (rash, swelling, breathing difficulty)

Bad signs

Brown or dark powder indicates oxidation/impuritiesCloudy solution after mixing indicates degradation/contamination
Was it helpful?Yes

Comments

0.0

0 reviews

5

4

3

2

1

No comments yet

Be the first to share your experience. Your review helps others make more informed decisions.

Frequently asked questions

What benefits can peptides offer in research?

Peptides can support cellular repair, immune function, metabolic health, and tissue regeneration. Research suggests they may help with recovery, sleep quality, skin health, and cognitive function, depending on the specific peptide and its mechanism of action.

What are some exciting applications of peptides in modern science?

Current research explores peptides for longevity, muscle recovery, wound healing, metabolic disorders, and neuroprotection. Scientists are also investigating peptide-based drug delivery and targeted therapies that could offer more precise treatment options.

How do peptides influence health and wellness?

Peptides work by binding to receptors on cells and triggering specific biological responses. Depending on the peptide, they may promote growth hormone release, support collagen production, modulate inflammation, or influence neurotransmitter activity—each with different implications for health and wellness.

Where can I find the latest studies on peptide applications?

Peer-reviewed journals such as Nature, Science, and specialized publications like Peptides and the Journal of Peptide Science publish ongoing research. PubMed and Google Scholar are useful for searching studies by peptide name or condition.

Are there any guidelines for using peptides in research?

Research use of peptides typically follows institutional review board (IRB) protocols and regulatory guidelines. Dosage, administration route, and safety monitoring should align with published literature and applicable regulations in your jurisdiction.

What is the difference between peptides and proteins?

Peptides are short chains of amino acids (typically under 50), while proteins are longer chains that fold into complex structures. Peptides are often more stable, easier to synthesize, and can cross cell membranes more readily, making them attractive for therapeutic applications.

How should peptides be stored?

Most peptides require refrigeration (2–8°C) and protection from light. Reconstituted peptides often have shorter stability and may need to be used within days or weeks. Always follow the manufacturer's or research protocol's storage instructions.

Can peptides be taken orally?

Some peptides are bioavailable orally, but many are broken down by digestive enzymes before reaching the bloodstream. Subcutaneous injection, nasal administration, or other routes are often used in research to improve bioavailability. The optimal route depends on the specific peptide.

Melanotan IIResearch References

Melanotan II is a well studied compound

4Research references

Melanotan II

Melanotan II is a well studied compound

Erectile Dysfunction Phase II Trial

0.025mg/kg dose achieved 80% response rate with significant improvement in psychogenic ED over 3 months.

2000

Melanogenesis & UV Protection Study

0.16mg/kg daily for 10 days increased eumelanin and achieved natural tan without UV exposure.

1999

Female Sexual Arousal Disorder Trial

Single dose of 0.025mg/kg resulted in 73% of premenopausal women reporting arousal within 24 hours.

2004

Appetite Reduction Study

15% reduction in caloric intake observed through MC4R activation.

2001